<DOC>
	<DOCNO>NCT01302470</DOCNO>
	<brief_summary>The primary goal study evaluate use robotically -assisted device lead primary strategy heart resynchronization.This trial aim compare transvenous lead placement robotic lead placement cardiac resynchronization therapy .</brief_summary>
	<brief_title>Comparison Epicardial Versus Conventional Lead Placement Cardiac Resynchronization Therapy</brief_title>
	<detailed_description>A secondary goal explore link efficacy CRT inotropic contractile reserve measure dobutamine stress echocardiography .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Symptomatic NYHA class III IV heart failure idiopathic ischemic heart failure QRS interval great equal 130 msec Left ventricular end diastolic diameter great equal 55 mm leave ventricular ejection fraction less equal 35 Willingness participate Acute renal failure ; active GI bleeding ; unexplained fever may due infection untreated active infection acute stroke severe uncontrolled systemic hypertension severe systemic electrolyte imbalance severe concomitant illness drastically shorten life expectancy severe coagulopathy history severe COPD inability tolerate single lung ventilation History prior leave sided thoracotomy history recent intravenous drug use concomitant psychiatric diagnosis impair patient 's ability comply study protocol participation another investigational protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>biventricular pacing</keyword>
</DOC>